Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Oxford Nanopore Technologies Raises £48.4M in Private Financing

Oxford Nanopore Technologies Raises £48.4M in Private Financing

May 28, 2020
|
staff reporter

NEW YORK – Oxford Nanopore Technologies said on Tuesday that it has raised £48.4 million ($59.7 million) in funding from new investors and existing shareholders in Europe, the Middle East and Africa (EMEA); the US; and Asia.

The new funding adds to £109.5 million — £29.3 million in new capital and £80.2 million from the sale of secondary shares — the company raised at the end of 2019. It brings its total funding raised to date to approximately £530 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Open at Publication

Howard Hughes Medical Institute will be requiring its researchers to publish their work so it is immediately accessible to the public, ScienceInsider writes.

Truth and Science

The Huffington Post reports that Francis Collins, the director of the US National Institutes of Health, has urged Americans to recommit to reason.

Quick Tests to Be Given Out

About 150 million rapid coronavirus tests purchased by the US federal government are to be distributed to nursing homes, colleges, and the states, according to the New York Times.

Nature Papers Examine Molecular Pathways in Alzheimer's Disease, Diploid Potato Assembly, More

In Nature this week: multi-omic analysis of Alzheimer's disease brain samples, de novo assembly of a diploid potato, and more.

Oct
06
Featured Webinar

Understanding Human Pulmonary Fibrosis using Single-Cell Technologies

Sponsored by
10x Genomics

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure. 

Oct
08
Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Sponsored by
Genecentric

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct
13
Featured Webinar

Probing and Disrupting Oncogenic Gene Control via Targeted Protein Degradation

Sponsored by
Lexogen

This webinar will outline the use of targeted protein degradation (TPD) to understand transcriptional processes at a high kinetic resolution.

Oct
14
Featured Webinar

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

Sponsored by
Inivata

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

What's Popular?

In Sequencing

  1. UK Government Unveils New Genomic Healthcare Strategy

  2. Circulomics Wins $2M in NIH Grants to Develop DNA Library Prep Products for Long-Read Sequencing

  3. Alzheimer's Disease Linked to Epigenetic Changes in Multi-Omic Study

  4. Sema4, Janssen Partner on Patient Identification for Cancer Clinical Trials

  5. NIH Awards Two SBIR Grants Totaling $3.9M to Phase Genomics

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.